RT Journal Article
SR Electronic
T1 Factors Associated with Disease Severity and Mortality among Patients with Coronavirus Disease 2019: A Systematic Review and Meta-Analysis
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.08.07.20166868
DO 10.1101/2020.08.07.20166868
A1 Chidambaram, Vignesh
A1 Tun, Nyan Lynn
A1 Haque, Waqas Z
A1 Majella, Marie Gilbert
A1 Sivakumar, Ranjith Kumar
A1 Kumar, Amudha
A1 Hsu, Angela Ting-Wei
A1 Ishak, Izza A
A1 Nur, Aqsha A
A1 Ayeh, Samuel K
A1 Salia, Emmanuella L
A1 Zil-E-Ali, Ahsan
A1 Saeed, Muhammad A
A1 Sarena, Ayu PB
A1 Seth, Bhavna
A1 Ahmadzada, Muzzammil
A1 Haque, Eman F
A1 Neupane, Pranita
A1 Wang, Kuang-Heng
A1 Pu, Tzu-Miao
A1 Ali, Syed MH
A1 Arshad, Muhammad A
A1 Wang, Lin
A1 Baksh, Sheriza
A1 Karakousis, Petros C
A1 Galiatsatos, Panagis
YR 2020
UL http://medrxiv.org/content/early/2020/08/13/2020.08.07.20166868.abstract
AB Background Understanding the factors associated with disease severity and mortality in Coronavirus disease (COVID-19) is imperative to effectively triage patients. We performed a systematic review to determine the demographic, clinical, laboratory and radiological factors associated with severity and mortality in COVID-19.Methods We searched PubMed, Embase and WHO database for English language articles from inception until May 8, 2020. We included Observational studies with direct comparison of clinical characteristics between a) patients who died and those who survived or b) patients with severe disease and those without severe disease. Data extraction and quality assessment were performed by two authors independently.Results Among 15680 articles from the literature search, 109 articles were included in the analysis. The risk of mortality was higher in patients with increasing age, male gender (RR 1.45, 95%CI 1.23–1.71), dyspnea (RR 2.55, 95%CI 1.88–2.46), diabetes (RR 1.59, 95%CI 1.41–1.78), hypertension (RR 1.90, 95%CI 1.69–2.15). Congestive heart failure (OR 4.76, 95%CI 1.34–16.97), hilar lymphadenopathy (OR 8.34, 95%CI 2.57–27.08), bilateral lung involvement (OR 4.86, 95%CI 3.19–7.39) and reticular pattern (OR 5.54, 95%CI 1.24–24.67) were associated with severe disease. Clinically relevant cut-offs for leukocytosis(>10.0 ×109/L), lymphopenia(< 1.1 ×109/L), elevated C-reactive protein(>100mg/L), LDH(>250U/L) and D-dimer(>1mg/L) had higher odds of severe disease and greater risk of mortality.Conclusion Knowledge of the factors associated of disease severity and mortality identified in our study may assist in clinical decision-making and critical-care resource allocation for patients with COVID-19.Primary Funding Source None.Competing Interest StatementThe authors have declared no competing interest.Funding StatementWe did not receive any funding for the project.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No IRB approval was obtained as this is a non-human subjects research (ie) systematic review of approved studies.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesSupplementary document contains all the data that were extracted from the individual studies in the Forest Plot. The compiled data sheet will be made available to individuals on the basis of formal request to the corresponding author.